IMVT
#1167
Immunovant, Inc. - Common Stock
29.4 8 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.25%
Changement Mensuel
-20.86%
Evolution sur 6 mois
+17.22%
Changement Annuel
+53.46%
Clôture Précédente
30.4 7
Open
30.1 7
Low
28.6 1
High
30.6 0
Financials
- Market Capitalization 6.09 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.97
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1150 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 311.13 USD | +3.09% | +0.56% | +9.20% | +66.27% | 6.20 B USD | ||
| 1153 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.82 USD | -1.06% | -4.92% | -15.11% | -18.57% | 6.18 B USD | ||
| 1222 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 86.06 USD | +0.06% | +5.03% | -12.51% | +22.71% | 5.59 B USD | ||
| 1247 |  ERAS Erasca, Inc. - Common Stock | 15.46 USD | -3.56% | +4.88% | -3.19% | +557.87% | 5.41 B USD |